Elix, Inc. is an AI drug discovery and materials informatics company with the mission of "Rethinking Drug Discovery and Materials Development".
We support our clients from pharmaceutical companies, chemical manufacturers and academia through collaborative research.
Our clients are mainly from pharmaceutical companies, chemical manufacturers and academia.
We apply cutting-edge technology in deep learning and machine learning that makes molecular design processes of AI drug discovery and materials informatics far more efficient. Currently we provide proprietary technology with a focus on property prediction, molecular design and retrosynthesis analysis.
In addition to talented AI researchers and AI engineers, many of the team members have Ph.D. degrees and come from different specialities such as chemistry, biology and physics. This diverse lineup gives us the capability to always be on the cutting-edge of AI research and development.
We offer full assistance, from:
- Proposing the most promising model among the latest research in deep learning.
- Implementation of our selected model.
- Refinement and model optimization.
